Identification of Phase I and Phase II metabolites of Guanfu base a Hydrochloride in human urine

被引:0
|
作者
G. J. A J. Y.
J. G. Wang
Y. C. Sun
M. S. Gu
J. H. Wu
机构
[1] the First Affiliated Hospital of NanJing Medical University,Department of Clinical Pharmacology
[2] China Pharmaceutical University,Department of Phytochemistry
[3] China Pharmaceutical University,Center of Drug Metabolism & Pharmacokinetics
关键词
Guanfu base A hydrochloride; metabolism; glucuronides; sulfates;
D O I
10.1007/BF03220178
中图分类号
学科分类号
摘要
Guanfu base A is a novel arrhythmic drug candidate isolated from the tuber of a traditional Chinese herb. Phase I and Phase II metabolites of Guanfu base A (GFA) Hydrochloride were studied in human urine by means of liquid chromatography mass spectrometry (LC/MSD) and tandem mass spectrometry (MS/MS). For phase I metabolites, Guanfu base I (GFI) was separated by HPLC and identified by comparison with authentic reference for their retention times, molecular ion peaks, fragment ions, and UV spectra. GFA oxide was also indicate to exist in human urine. For phase II metabolites, after human urine was treated either with glucuronidase or sulfatase, GFA occured in the chromatograms. It was suggested that there were GFA glucuronide and GFA sulfate in human urine. Further more, positive molecular ions, m/z 606 and m/z 510, of the two conjugates were detected in human urine by LC/MSD. In addition, characteristic ion of m/z 606 was identified as the precursor ion of m/z 177 [Glucuronic acid+H]+ by using MS/MS. Characteristic ion of m/z 430 [GFA+H]+ was also identified as a product ion of m/z 606 [GFA glucuronide+H]+. It was concluded that there were GFI, GFA oxide, GFA glucuronide and GFA sulfate in human urine.
引用
收藏
页码:265 / 272
页数:7
相关论文
共 50 条
  • [21] CHEMICAL SYNTHESIS OF PHASE-I-METABOLITES AND PHASE-II-METABOLITES OF ANTIPYRINE
    KROHN, K
    STENNS, C
    ARCHIV DER PHARMAZIE, 1989, 322 (06) : 351 - 354
  • [22] Metabolism of the designer drug α-pyrrolidinobutiophenone (α-PBP) in humans: Identification and quantification of the phase I metabolites in urine
    Matsuta, Shuntaro
    Shima, Noriaki
    Kamata, Hiroe
    Kakehashi, Hidenao
    Nakano, Shihoko
    Sasaki, Keiko
    Kamata, Tooru
    Nishioka, Hiroshi
    Miki, Akihiro
    Katagi, Munehiro
    Zaitsu, Kei
    Sato, Takako
    Tsuchihashi, Hitoshi
    Suzuki, Koichi
    FORENSIC SCIENCE INTERNATIONAL, 2015, 249 : 181 - 188
  • [23] An HPLC assay for carbamazepine phase I metabolites and their glucuronides in urine
    Reith, DM
    Cannell, GR
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1999, 22 (12) : 1907 - 1918
  • [24] LC-ESI-MS/MS identification and characterization of ponatinib in vivo phase I and phase II metabolites
    Attwa, Mohamed W.
    Kadi, Adnan A.
    Darwish, Hany W.
    Amer, Sawsan M.
    AlRabiah, Haitham
    CLINICA CHIMICA ACTA, 2018, 485 : 144 - 151
  • [25] Isolation and identification of phase I metabolites of butyrolactone I in rats
    An, X.
    Feng, B. -M.
    Chen, G.
    Chen, S. -F.
    Bai, J.
    Hua, H. -M.
    Wang, H. -F.
    Pei, Y. -H.
    XENOBIOTICA, 2017, 47 (03) : 236 - 244
  • [26] Isolation and identification of phase I metabolites of phillyrin in rats
    Li, Chang
    Yao, Zhi-Hong
    Qin, Zi-Fei
    Zhang, Jin-Bo
    Cao, Rui-Yuan
    Dai, Yi
    Yao, Xin-Sheng
    FITOTERAPIA, 2014, 97 : 92 - 97
  • [27] Isolation and identification of phase I metabolites of resibufogenin in rats
    Zhu, Z-T.
    Deng, S.
    Liu, D.
    Zhang, B. -J.
    Sun, H. -Z.
    Tian, Y.
    Wang, C. -Y.
    Wang, Li
    Ma, X. -C.
    XENOBIOTICA, 2013, 43 (05) : 479 - 485
  • [28] IDENTIFICATION OF PHASE-I AND PHASE-II METABOLITES OF FLUPHENAZINE IN RAT BILE - INTACT GLUCURONIDE AND SULFATE CONJUGATES
    JACKSON, CJC
    HUBBARD, JW
    MCKAY, G
    COOPER, JK
    HAWES, EM
    MIDHA, KK
    DRUG METABOLISM AND DISPOSITION, 1991, 19 (01) : 188 - 193
  • [29] Synthesis and characterization of some new phase II metabolites of the alkylator bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinoma
    Teichert, J
    Sohr, R
    Baumann, F
    Hennig, L
    Merkle, K
    Caca, K
    Preiss, R
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (07) : 984 - 992
  • [30] PHARMACOLOGICAL EFFECTS OF PHASE-I AND PHASE-II METABOLITES OF TRIAMTERENE
    KNAUF, H
    MUTSCHLER, E
    VOLGER, KD
    WAIS, U
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1978, 28-2 (08): : 1417 - 1420